Navigation Links
FASEB President Addresses Congressional Audience at Coalition for Health Funding Briefing on Public Health
Date:3/2/2010

BETHESDA, Md., March 2 /PRNewswire-USNewswire/ -- Federation of American Societies for Experimental Biology (FASEB) President Mark O. Lively, Ph.D., addressed a Capitol Hill audience, including congressional staff, and members of the Coalition for Health Funding (CHF) today to describe the critical role biomedical research plays in improving public health. "At a time when our nation is searching for ways to repair and improve our troubled healthcare system, I am here to reemphasize the importance of providing steady and sustained funding for biomedical research in the United States," Lively stated during the CHF-organized event titled, Public Health 101: Building Capacity to Meet America's Mounting Health Needs.

Lively pointed out the drastic toll chronic disease takes on both health care spending and the lives of patients suffering from these conditions. "But the good news," he added, "is that biomedical research has contributed significantly to improved health and the opportunities for continued progress have never been brighter." Lively acknowledged the challenge presented by the country's current economic situation, but reiterated the value of our investment in the National Institutes of Health (NIH). "Now is not the time to pull back from our historic commitment to investigation and discovery," he said. "Fundamental scientific discoveries funded by NIH form the basis for the ongoing transformation of the practice of medicine." He went on to list a number of NIH's recent accomplishments in advancing medicine and health, including dramatic reductions in deaths from heart disease and cancer and development of a host of new drug therapies.

In concluding, Lively highlighted the future promise of an accelerated pace of discovery. "We are at the beginning of a whole new era of pharmacogenomics that will identify ways to tailor treatments and scientifically match therapies to individuals," he declared, describing how advances in genomic sequencing have already led to the dawn of personalized medicine. "Continued progress towards that goal depends on sustained and predictable funding support for NIH... one critical part of the prescription for improved health. Research means hope."

For the full transcript of Lively's remarks, please see: http://opa1.faseb.org/pages/LG/livelyCHFspeech.htm

FASEB is composed of 23 societies with more than 90,000 members, making it the largest coalition of biomedical research associations in the United States. FASEB enhances the ability of scientists and engineers to improve -- through their research -- the health, well-being and productivity of all people. Our mission is to advance health and welfare by promoting progress and education in biological and biomedical sciences through service to our member societies and collaborative advocacy.

SOURCE Federation of American Societies for Experimental Biology

Back to top

RELATED LINKS
http://www.faseb.org

'/>"/>

SOURCE Federation of American Societies for Experimental Biology
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Amira Pharmaceuticals to Present Preclinical Data from LPA1 Receptor Antagonist Program at FASEB Summer Research Conference
2. President Obama Gets Virtual Colonoscopy (CT Colonography) But Medicare Denies CTC Coverage to Seniors
3. Landrieu Comments on Presidents Small Business Health Care Report
4. DNC Chairman Tim Kaine Applauds President, Members of Congress on Todays Bipartisan Summit
5. DNC Hispanic Caucus Chairwoman Praises President Obamas Leadership on Bipartisan Health Reform Summit
6. AFL-CIO President Richard Trumka to Discuss TSA Bargaining Rights on Inside Government Radio Show
7. Alan Chapell, President of Chapell & Associates to Deliver Keynote at the Next AdMonsters US Leadership Forum
8. LocumTenens.com Names Lisa Kaeck Executive Vice President
9. Sensaria Names Kathy Bintz-Fertitta as New President
10. Comments by American Dental Association President Dr. Ron Tankersley on the Pew Center on the States report The Cost of Delay: State Dental Policies Fail One in Five Children
11. Ricochet PR Names Valerie Carter Vice President of Washington, D.C. Public Affairs Practice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... VisualSP has ... sustainably. Until recently, the only option for on-premises installation of its Help System for ... required to install the system into the entire tenant. , The company recently ...
(Date:3/28/2017)... ... March 28, 2017 , ... India’s Chigurupati Technologies announced ... address the resolution to globally reduce the harmful use of alcohol set forth ... and TTB approved ingredients that when infused into alcohol, renders the alcohol liver ...
(Date:3/28/2017)... ... 29, 2017 , ... The Thyroid Secret is a specialized ... The program was recently launched on March 1, and Dr. Wentz discussed varied ... , Dr. Izabella Wentz is a licensed pharmacist and a foremost thyroid specialist. ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... the science and clinical practice of radiosurgery, announced today the publication of ... observational registry established to standardize data collection from patients treated with stereotactic ...
(Date:3/28/2017)... ... March 28, 2017 , ... WHO: , Dr. Paul Thomas; Dr. ... , Medical doctors and PhD scientists will speak to the press on behalf of ... support of an independent vaccine safety commission. , WHERE: , Zenger Room, National ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... /PRNewswire/ - Medicure Inc. ("Medicure") (TSXV:MPH, OTC:MCUJF), a specialty ... year ended December 31, 2016 after market close ... being released later than the previous fiscal year,s ... operations and balances of Apicore from the acquisition ... filing date meets TSX Venture Exchange listed company ...
(Date:3/28/2017)... 28, 2017 The global emerging cancer diagnostics ... 13.45% from 2016 to 2023 and reach a figure ... Cancer is a chronic disease and is affecting a ... diagnostics market. This report is focused on emerging cancer ... growth is propelled due to factors such as: increasing ...
(Date:3/28/2017)... SPRING, Md. , March 28, 2017 /PRNewswire-USNewswire/ ... approved Dupixent (dupilumab) injection to treat adults with ... patients whose eczema is not controlled adequately by ... are not advisable. Dupixent can be used with ... of Dupixent demonstrates our commitment to approving new ...
Breaking Medicine Technology: